首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of tetrazole derivatives bearing pyrrolidine scaffold and evaluation of their antifungal activity against Candida albicans
【24h】

Synthesis of tetrazole derivatives bearing pyrrolidine scaffold and evaluation of their antifungal activity against Candida albicans

机译:含有吡咯烷支架的四唑衍生物的合成及其对念珠菌念珠菌的抗真菌活性评价

获取原文
获取原文并翻译 | 示例
           

摘要

The increase of opportunistic fungal infections raises the need for design and synthesis of new antifungal agents. Taking into account that tetrazole derivatives exhibit antifungal activity, and some of them are in the phase of clinical trials, new tetrazole derivatives bearing pyrrolidine moiety were synthesized in order to present their action mode against C albicans. The target compounds were obtained by N-alkylation of various 2-arylpyrrolidines with several 1-(3-chloropropyl)-5-aryl-2H-tetrazoles. Regardless of the substituents at tetrazole or pyrrolidine rings reactions took place in 48 h and with satisfactory yields ranging from 53 to 70%. We performed screen of the synthesized compounds to identify these nontoxic inhibiting the C albicans planktonic and sessile cells, and conducted a series of follow up studies to examine the in vitro and in vivo activity of the most potent antifungals. The leading antifungal inhibitor: 2-{3-[2-(3-Methylphenyl)pyrrolidin-1-yl]propyl)-5-phenyl-2H-tetrazole (3aC) and the randomly selected ones: 5-phenyl-2-[3-(2-phenylpyrrolidin-1-yl)propyl]-2H-tetrazole (3aA), 5-(4-chlorophenyl)-2-(3-[2-(4-fluorophenyl)pyrrolidin-1-yl]propyl}-2H-tetrazole (3cD), and 5-(4-chlorophenyl)-2-(3-[2-(4-chlorophenyl)pyrrolidin-1-yl]propyl}-2H-tetrazole (3cE) showed little to no toxicity against the Vero cell line and Galleria mellonella. 3aC and 3aD, the most active against biofilm in vitro, demonstrated in vivo activity in the invertebrate model of disseminated candidiasis. Flow cytometry analysis showed that necrotic cell death was generated under 3aC due to its interactions with the fungal membrane; this confirmed by the mitochondrial damage (XTT assay) and reduced adhesion to the TR-146 cell line at 46.05 mu M. Flow cytometry was used to directly measure the redox state of the treated cells with the fluorescent DCFH probe. Pro-necrotic tetrazole derivatives (3aA, 3aC, 3cD) are unable to induce ROS production in the C albicans cells. Moreover, CLSM analyses revealed that the tetrazole derivatives (principally 3aC, 3aD, and 3aE) inhibit C albicans' ability to neutralize macrophages; a more effective phagosomes organisation was observed. 3aC's and 3aD's activity reflected in an attenuation of virulence in disseminated candidiasis in vivo. (C) 2018 Elsevier Masson SAS. All rights reserved.
机译:机会性真菌感染的增加提高了对新的抗真菌剂的设计和合成的需求。考虑到四唑衍生物表现出抗真菌活性,并且其中一些是临床试验的阶段,合成了含有吡咯烷部分的新的四唑衍生物,以便向C醛糖醛醛蛋白呈现它们的作用模式。通过具有几种1-(3-氯丙基)-5-芳基-2H-四唑的各种2-芳基吡咯烷酯的N-烷基化获得目标化合物。无论四唑或吡咯烷环反应的取代基在48小时内发生,令人满意的产率范围为53至70%。我们对合成化合物进行了筛选,以鉴定这些无毒抑制C醛糖粉氏菌(Calankicanc和术所述细胞),并进行一系列后续研究,以检查体外和最有效的抗真菌的体外活性。领先的抗真菌抑制剂:2- {3- [2-(3-甲基苯基)吡咯烷-1-基]丙基)-5-苯基-2H-四唑(3Ac)和随机选择的:5-苯基-2- [ 3-(2-苯基吡咯烷-1-基)丙基] -2H-四唑(3AA),5-(4-氯苯基)-2-(3- [2-(4-氟苯基)吡咯烷-1-YL]丙基} -2H-四唑(3CD)和5-(4-氯苯基)-2-(3- [2-氯苯基)吡咯烷-1-基]丙基} -2H-四唑(3CE)显示出没有毒性针对VERO细胞系和Galleria Mellonella。3AC和3AD,对体外最活跃的生物膜,在传播念珠菌病的无脊椎动物模型中展示了体内活性。流式细胞术分析显示,由于其与其相互作用,在3AC下产生坏死的细胞死亡真菌膜;通过线粒体损伤(XTT测定)证实并降低了在46.05μmM的Tr-146细胞系中的粘附性。流式细胞术用荧光DCFH探针直接测量处理过的细胞的氧化还原状态。Pro -Necric四唑衍生物(3AA,3AC,3CD)不能在C醛鸟类细胞中诱导ROS产生。此外,CLSM分析显示,四唑衍生物(主要是3AC,3AD和3AE)抑制C albicans中和巨噬细胞的能力;观察到更有效的吞噬体组织。 3AC和3AD的活动反映在体内散发念珠菌病中的毒力衰减。 (c)2018年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号